Monthly Prescribing Reference

Novel Steroid Eye Drop Reduces Pain, Inflammation After Cataract Surgery

Credit: Getty Images. OCS-01 is a novel, high concentration (15mg/mL), topical formulation of dexamethasone. Once-daily administration of an investigational corticosteroid eye drop (OCS-01) was found ...
Business Insider

Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication

NASHVILLE, Tenn., March 03, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that the U.S. Food and Drug ...
Healio

Oculis begins phase 3 trial of new steroid for post-cataract surgery pain, inflammation

Please provide your email address to receive an email when new articles are posted on . Oculis has completed the first patient visit in its phase 3 OPTIMIZE-2 trial of OCS-01, the company’s ...
ksn.com

Positive Results from Phase 3 OPTIMIZE-1 Trial of Once Daily OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery Presented at the 2024 American Society ...

OCS-01 positive results in the first Phase 3 OPTIMIZE-1 trial were presented at the American Society of Cataract and Refractive Surgery (ASCRS) while topline readout from the second Phase 3 OPTIMIZE-2 ...
Nasdaq

OCS-01, First Investigational Eye Drop for Front and Back of the Eye, Met Both Primary Endpoints in Phase 3 OPTIMIZE Trial with a Once Daily Regimen for the Treatment of ...

OPTIMIZE (Once-daily Post-ocular surgery Treatment for InflaMmation and paIn to minimiZE drops) is a double-blind, placebo-controlled Phase 3 trial conducted in 25 sites across the US with 241 ...
Medscape

Cataract and Refractive Surgery News

SSRIs May Boost Risk for Cataracts SSRIs have been linked to an increased risk for cataracts, but researchers say the effect size is modest and needs to be investigated further. Medscape Medical News, ...